AGENDA:
- How did martial law influence the market of medical devices in Ukraine?
- How is the registration process for medical devices is organized in Ukraine?
- Is it possible to recognize an MDR CE certificate?
Recognition of EC certificatesfor medical devices and IVDs in Ukraine. Maksy...Maksym Bagrieiev
Technical regulations in Ukraine: where we are now and how we got there. National legislation: Technical regulations and other legal acts. Authorized representative in Ukraine. Language and labeling requirements. Conformity assessment bodies and international standards. Conformity assessment procedures. What problems can be solved by recognition. Legal requirements for recognition in details. List of notified bodies signed Agreements with UA CABs.
Step-by-step process. What should be considered prior to apply for recognition. Impact of changes in EU to UA certificate. Changes and renewals. Post-marketing activities. Other Technical regulations. Market supervision.
Insights on the MedTech Regulatory and Clinical Environment in IsraelGreenlight Guru
Facts about the high-tech industry of Israel
The new medical device law in Israel
The regulatory landscape - requirements and market access
Performing clinical trials in Israel
This presentation originally aired during the 2022 Global MedTech Regulatory Trends Virtual Summit.
Medical device classification following MDR 2017/745Monir EL AZZOUZI
MDR 2017/745 Medical Device Classification. What are the regulatory changes for the new Medical Device Regulation. What is new on the classification of the products. Annex VIII contains 22 rules with 4 new rules. Receive a free form to download and some infographic. This slidedeck is provided by Easy Medical Device. #medtech #medicaldevice #medicaldevices
NSF International and its role in Dietary supplements & Nutraceutical industr...SyedArshiya4
This presentation will allow the reader to know about NSF international its history, mission, NSF Mark, role in Dietary supplements and Nutraceutical industries. It also give information on testing, inspection, certification of products.
Recognition of EC certificatesfor medical devices and IVDs in Ukraine. Maksy...Maksym Bagrieiev
Technical regulations in Ukraine: where we are now and how we got there. National legislation: Technical regulations and other legal acts. Authorized representative in Ukraine. Language and labeling requirements. Conformity assessment bodies and international standards. Conformity assessment procedures. What problems can be solved by recognition. Legal requirements for recognition in details. List of notified bodies signed Agreements with UA CABs.
Step-by-step process. What should be considered prior to apply for recognition. Impact of changes in EU to UA certificate. Changes and renewals. Post-marketing activities. Other Technical regulations. Market supervision.
Insights on the MedTech Regulatory and Clinical Environment in IsraelGreenlight Guru
Facts about the high-tech industry of Israel
The new medical device law in Israel
The regulatory landscape - requirements and market access
Performing clinical trials in Israel
This presentation originally aired during the 2022 Global MedTech Regulatory Trends Virtual Summit.
Medical device classification following MDR 2017/745Monir EL AZZOUZI
MDR 2017/745 Medical Device Classification. What are the regulatory changes for the new Medical Device Regulation. What is new on the classification of the products. Annex VIII contains 22 rules with 4 new rules. Receive a free form to download and some infographic. This slidedeck is provided by Easy Medical Device. #medtech #medicaldevice #medicaldevices
NSF International and its role in Dietary supplements & Nutraceutical industr...SyedArshiya4
This presentation will allow the reader to know about NSF international its history, mission, NSF Mark, role in Dietary supplements and Nutraceutical industries. It also give information on testing, inspection, certification of products.
Презентація вебінару “Як правильно маркувати медичні вироби? Вимоги стандарт...Improve Medical LLC
ПЛАН ВЕБІНАРУ:
- маркування медичних виробів в Україні;
- знаки, які наносяться на медичні вироби;
- вимоги щодо маркування медичних виробів, завезених з території ЄС.
Japan Medical Device Regulatory Approval ProcessKate Jablonski
Before deciding to sell your device in the Japanese market, it is important to understand how the regulations apply to your device, which steps to take, and what resources are required to complete the process. In this presentation, Ann Marie Boullie, Vice President of Business Development for EMERGO, outlines some of the most complex aspects of the Japanese registration process, including:
JMDN codes: device classification and predicates
Clinical data requirements and PMDA pre-submission meetings
Registration routes (Todokede, Ninsho, Shonin)
QMS (Ordinance 169) requirements
Role of the Marketing Authorization Holder (MAH)
GCC countries, Drug registration regulations of Saudi Arabia, Medicinal Product Registration process (SA), Drug Registration Requirement (SA), Post Registration Requirements in (SA), Drug registration regulations UAE Medicinal Product Registration process (UAE), Drug Registration Requirement (UAE).
Since 2003, The Saudi Food and Drug Authority (SFDA) is the competent authority for registrations, maintenance, quality, pharmacovigilance and import of medicinal products.
SFDA is responsible for handling and licensing the manufacture, import, export, distribution, promotion, and advertising of medicinal products.
The SFDA is also responsible for assessing the safety, efficacy, and quality of medicinal products, issuing marketing authorizations, and monitoring the quality & safety of the marketed medicinal products.
SFDA prefers the drug dossier submission in electronic format (eCTD).
It is an independent authority from the Ministry of Health.
Market Authorization
The process of submitting a new Marketing Authorization Application (MAA) consists of the following phases:
Phase 1
Step 1: Online Registration on the Drug Establishments National Registry (DENR)
The applicant register online on the DENR to get a username and password, which enables the applicant to log in and avail all the electronic services of the drug sector.
Step 2: Marketing Authorization Application (MAA) Submission:
The applicant shall apply through the Saudi Drug Registration (SDR) system to fill out the application form and pay the fees.
Upload the eCTD file to the system through the SDR system portal.
A soft copy of the eCTD should be submitted labelled as per the SFDA guideline, along with the hard copies of the original documents.
Phase 2
Step 1: Validation
The product file will be validated on technical and business bases to ensure that the applicant fulfils the requirement.
Step 2 - Assessment, Testing and Inspection
The relevant departments will evaluate the MAA to assess quality, safety, and efficacy, along with the onsite GMP inspection and sample analysis by the SFDA central laboratories.
Step 3 - Pricing
The Pricing Department will review the product’s price according to the “SFDA's pricing rules.”
Step 4 - Product Licensing
The Registration Committee will review the registration request for approval.
Verification and Abridged Procedure
Verification Process
This process will be applicable if the product has been approved and marketed by both the European Medicines Agency (EMA) and the United States Food and Drug Administration (USFDA).
For all pharmaceutical items, even those that are not intended to be used as medicines, such as nutritional supplements and cosmetics, to be registered with the Ministry of Health & Prevention (MOHAP) in the United Arab Emirates.
The UAE government takes all necessary measures to ensure that safety standards and procedures are followed in cases of import, export, trade, and sale of products, which are consumed or used by the people.
Devices Sponsor Information Day: 1 - Conformity AssessmentTGA Australia
Presentations by TGA and Industry (combined) to help sponsors and manufacturers better understand the regulation of medical devices and in-vitro diagnostic medical devices
Презентація вебінару "Введення MDR на території Європейського Союзу Основні з...Improve Medical LLC
ПЛАН ВЕБІНАРУ:
• Введення MDR на території Європейського Союзу з 26 травня 2021 року.
• Які вимоги у здійснення моніторингу ринку були змінені?
• Які функції особи, відгалуження за дотримання регуляторних вимог?
• Які принципи ідентифікації медичних виробів було змінено?
• Чи буде введений MDR в Україні?
The regulation of medical devices in AustraliaTGA Australia
View this presentation for information on:
* what are medical devices, and how they compare to medicines in terms of regulation
* the process for a device to get to market and how they are classified according to risk
* the essential principles and conformity assessment
* safety and performance of devices.
Regulatory requirements for CE CERTIFICATION of Medical Devices in European U...Pallavi Christeen
The EU introduced the CE marking scheme to make trade easier and cheaper between EU countries. It means that a manufacturer claims that their product conforms to the minimum legal requirements for health and safety as laid down in EU directives. In addition, it may be considered a benefit that by implementing the requirements, the product will be safer for the user and this may also reduce damage and liability claims. Additional benefits may include your product being made safer for end-users. The EU introduced the CE marking scheme to make trade easier and cheaper between EU countries. It means that a manufacturer claims that their product conforms to the minimum legal requirements for health and safety as laid down in EU directives. If you manufacture or import a product which falls within the scope of one or more of the New Approach Directives and wish to place your product on the market in any of the member’s states of the European Economic Area (EEA), then you must apply CE marking to your product against the essential requirements of all these applicable directives.
Key Words: European Union, CE marking, New Approach Directives, EEA, Regulatory requirements.
overview of Anvisa Requirements, Medical device classification and grouping, cadostro registration pathway,resgistro pathway,INMETRO Certification, Summary of Anvisa Registration Process
Conduction of a remote audit in Ukraine. How is it organized?Improve Medical LLC
MEETING AGENDA:
- When is the remote audit possible and what are the requirements?
- What does the conformity assessment body expect during the audit?
- How to fill in the Checklist for the audit and other documents?
Tuv sud-ivdr-infosheet - EU’s In Vitro Diagnostic Medical Device RegulationStefano Bolletta
EU’s In Vitro Diagnostic Medical Device Regulation
A quick guide to the new IVDR.
The EU’s in vitro diagnostic medical device
regulation
Manufacturers of in vitro diagnostic medical devices
seeking market access to the European Union (EU)
will soon face major changes in the EU’s decades-old
regulatory framework. The EU’s In vitro diagnostic
medical device regulation (IVDR) was officially
published on 5 May 2017 and came into force on
26 May 2017. The IVDR will replace the EU’s current
directive on in vitro diagnostic medical devices
(98/79/EC).
Презентація вебінару “Як правильно маркувати медичні вироби? Вимоги стандарт...Improve Medical LLC
ПЛАН ВЕБІНАРУ:
- маркування медичних виробів в Україні;
- знаки, які наносяться на медичні вироби;
- вимоги щодо маркування медичних виробів, завезених з території ЄС.
Japan Medical Device Regulatory Approval ProcessKate Jablonski
Before deciding to sell your device in the Japanese market, it is important to understand how the regulations apply to your device, which steps to take, and what resources are required to complete the process. In this presentation, Ann Marie Boullie, Vice President of Business Development for EMERGO, outlines some of the most complex aspects of the Japanese registration process, including:
JMDN codes: device classification and predicates
Clinical data requirements and PMDA pre-submission meetings
Registration routes (Todokede, Ninsho, Shonin)
QMS (Ordinance 169) requirements
Role of the Marketing Authorization Holder (MAH)
GCC countries, Drug registration regulations of Saudi Arabia, Medicinal Product Registration process (SA), Drug Registration Requirement (SA), Post Registration Requirements in (SA), Drug registration regulations UAE Medicinal Product Registration process (UAE), Drug Registration Requirement (UAE).
Since 2003, The Saudi Food and Drug Authority (SFDA) is the competent authority for registrations, maintenance, quality, pharmacovigilance and import of medicinal products.
SFDA is responsible for handling and licensing the manufacture, import, export, distribution, promotion, and advertising of medicinal products.
The SFDA is also responsible for assessing the safety, efficacy, and quality of medicinal products, issuing marketing authorizations, and monitoring the quality & safety of the marketed medicinal products.
SFDA prefers the drug dossier submission in electronic format (eCTD).
It is an independent authority from the Ministry of Health.
Market Authorization
The process of submitting a new Marketing Authorization Application (MAA) consists of the following phases:
Phase 1
Step 1: Online Registration on the Drug Establishments National Registry (DENR)
The applicant register online on the DENR to get a username and password, which enables the applicant to log in and avail all the electronic services of the drug sector.
Step 2: Marketing Authorization Application (MAA) Submission:
The applicant shall apply through the Saudi Drug Registration (SDR) system to fill out the application form and pay the fees.
Upload the eCTD file to the system through the SDR system portal.
A soft copy of the eCTD should be submitted labelled as per the SFDA guideline, along with the hard copies of the original documents.
Phase 2
Step 1: Validation
The product file will be validated on technical and business bases to ensure that the applicant fulfils the requirement.
Step 2 - Assessment, Testing and Inspection
The relevant departments will evaluate the MAA to assess quality, safety, and efficacy, along with the onsite GMP inspection and sample analysis by the SFDA central laboratories.
Step 3 - Pricing
The Pricing Department will review the product’s price according to the “SFDA's pricing rules.”
Step 4 - Product Licensing
The Registration Committee will review the registration request for approval.
Verification and Abridged Procedure
Verification Process
This process will be applicable if the product has been approved and marketed by both the European Medicines Agency (EMA) and the United States Food and Drug Administration (USFDA).
For all pharmaceutical items, even those that are not intended to be used as medicines, such as nutritional supplements and cosmetics, to be registered with the Ministry of Health & Prevention (MOHAP) in the United Arab Emirates.
The UAE government takes all necessary measures to ensure that safety standards and procedures are followed in cases of import, export, trade, and sale of products, which are consumed or used by the people.
Devices Sponsor Information Day: 1 - Conformity AssessmentTGA Australia
Presentations by TGA and Industry (combined) to help sponsors and manufacturers better understand the regulation of medical devices and in-vitro diagnostic medical devices
Презентація вебінару "Введення MDR на території Європейського Союзу Основні з...Improve Medical LLC
ПЛАН ВЕБІНАРУ:
• Введення MDR на території Європейського Союзу з 26 травня 2021 року.
• Які вимоги у здійснення моніторингу ринку були змінені?
• Які функції особи, відгалуження за дотримання регуляторних вимог?
• Які принципи ідентифікації медичних виробів було змінено?
• Чи буде введений MDR в Україні?
The regulation of medical devices in AustraliaTGA Australia
View this presentation for information on:
* what are medical devices, and how they compare to medicines in terms of regulation
* the process for a device to get to market and how they are classified according to risk
* the essential principles and conformity assessment
* safety and performance of devices.
Regulatory requirements for CE CERTIFICATION of Medical Devices in European U...Pallavi Christeen
The EU introduced the CE marking scheme to make trade easier and cheaper between EU countries. It means that a manufacturer claims that their product conforms to the minimum legal requirements for health and safety as laid down in EU directives. In addition, it may be considered a benefit that by implementing the requirements, the product will be safer for the user and this may also reduce damage and liability claims. Additional benefits may include your product being made safer for end-users. The EU introduced the CE marking scheme to make trade easier and cheaper between EU countries. It means that a manufacturer claims that their product conforms to the minimum legal requirements for health and safety as laid down in EU directives. If you manufacture or import a product which falls within the scope of one or more of the New Approach Directives and wish to place your product on the market in any of the member’s states of the European Economic Area (EEA), then you must apply CE marking to your product against the essential requirements of all these applicable directives.
Key Words: European Union, CE marking, New Approach Directives, EEA, Regulatory requirements.
overview of Anvisa Requirements, Medical device classification and grouping, cadostro registration pathway,resgistro pathway,INMETRO Certification, Summary of Anvisa Registration Process
Conduction of a remote audit in Ukraine. How is it organized?Improve Medical LLC
MEETING AGENDA:
- When is the remote audit possible and what are the requirements?
- What does the conformity assessment body expect during the audit?
- How to fill in the Checklist for the audit and other documents?
Tuv sud-ivdr-infosheet - EU’s In Vitro Diagnostic Medical Device RegulationStefano Bolletta
EU’s In Vitro Diagnostic Medical Device Regulation
A quick guide to the new IVDR.
The EU’s in vitro diagnostic medical device
regulation
Manufacturers of in vitro diagnostic medical devices
seeking market access to the European Union (EU)
will soon face major changes in the EU’s decades-old
regulatory framework. The EU’s In vitro diagnostic
medical device regulation (IVDR) was officially
published on 5 May 2017 and came into force on
26 May 2017. The IVDR will replace the EU’s current
directive on in vitro diagnostic medical devices
(98/79/EC).
Post-marketing safety surveillance of medical devices and drug-device combina...Arete-Zoe, LLC
ISoP Medical Device SIG Webinar on Post-marketing safety surveillance of medical devices and drug-device combination products
https://isoponline.org/special-interest-groups/medical-devices-group/
PMS is an integral part of a quality management system described in ISO 13485. ISO 13485 references inclusion of applicable regulatory requirements on post market surveillance into the quality management system.
Regulatory requirements are country specific and are continuously evolving. The regulatory processes for devices are significantly different than for drugs. Moreover, the requirements for drug-device combination products are not always clearly articulated.
• In Europe, according to the EU MDR, post-market surveillance shall also allow a comparison to be made between the device and similar products available on the market.
• The first challenge is identifying similar products on the market, that is out of the scope of this webinar. The second challenge is finding relevant information on equivalent and similar products.
• Since EUDAMED does not currently have a post-marketing module, manufacturers have to rely on a large number of national databases. The focus of this webinar is on regulatory requirements in major jurisdictions. There will be another webinar coming soon that will focus on how to obtain the information required to comply with all these requirements.
• With some effort, it is possible to locate information on advisory notices.
• However, adverse events or incidents are not publicly available. This is a major difference from medicinal products.
• In addition, certain AEs are subject to the National Competent Authority Report (NCAR) Exchange. These reports are shared between agencies and can potentially result in FSCA. So even when unable to monitor competitor product adverse event profile, it is important to know about their FSCAs.
The EU’s medical device regulation
Medical device manufacturers seeking market access
to the European Union (EU) will soon face major changes
in the EU’s decades-old regulatory framework. The EU’s
Medical Device Regulation (MDR) was officially published
on 5 May 2017 and came into force on 25 May 2017.
The MDR will replace the EU’s current Medical Device
Directive (93/42/EEC) and the EU’s Directive on active
implantable medical devices (90/385/EEC).
Presentation: Update from the Medical Devices BranchTGA Australia
Under Recommendation 15 of the Review of Medicines and Medical Review Regulation (MMDR) the Government agreed to greater utilisation of marketing approvals by comparable overseas regulators to support assessments of medical devices in Australia. Legislative amendments in the Therapeutic Goods Amendment (2017 Measures No. 1) Act 2018 to enact this change also included clarifications regarding preliminary assessment of applications for pre-market authorisation. This presentation will review the implementation arrangements for these changes, covering the increased options for use of overseas approvals, and the evidence requirements to support applications.
Insights about changes to the EU's MDR (Medical Device Regulations) by Ulf Grundmann, Partner, King & Spalding, August 17, 2020. Includes scope and definitions, classification and conformity assessment, placing a device on the EU marketin, UDI and EUDAMED, supply chain obligations, PMS, compliance and vigilance.
Presentation on what it takes to get a clinical study off the ground in the UK along with some info on the impact of directive 2007/47/EC will have on clinical data requirements
Medical Device Regulation (MDR) overview for Technion, May 25, 2021Levi Shapiro
On May 26, 2021, the EU introduced the most sweeping changes to the Medical Device legal framework since the mid 90's. Ulf Grundmann, Senior Partner, King & Spalding (Frankfurt), reviews some of these regulatory changes, from the perspective of medical device innovators. The presentation includes Scope and Definitions, Classification and Conformity Assessment, Placing a Device on the EU Market, UDI and EUDAMED, Supply Chain Obligations, PMS and Vigilance
This Circular provides for emergency marketing authorization of COVID-19 vaccines (hereinafter referred to as “vaccines"), specifically:
1. Applications and procedures for vaccine marketing authorization issuance, renewal and amendment.
2. Requirements for clinical data in applications to ensure vaccine safety and effectiveness.
3. Exemption from one or more than one clinical trial phase and vaccines required to undergo phase 4 clinical trial in Vietnam.
1. This Circular elaborates Decree No. 98/2021/ND-CP dated November 8, 2021 of the Government on management of medical devices (hereinafter referred to as “Decree No. 98/2021/ND-CP”).
a) Classification of medical devices under Clause 5 Article 5 of Decree No. 98/2021/ND-CP;
b) Addition to the list of in vitro diagnostic medical devices that are not required to undergo quality inspection by Vietnam’s competent authorities under Point dd Clause 3 Article 30 of Decree No. 98/2021/ND-CP;
c) List of class B, class C, and class D medical devices purchased and sold as common commodities mentioned under Clause 1 Article 42 of Decree No. 98/2021/ND-CP;
d) List of medical devices to be inspected for safety and technical functions under Clause 10 Article 70 of Decree No. 98/2021/ND-CP;
dd) List of medical devices to be granted import permit under Point d Clause 2 Article 76 of Decree No. 98/2021/ND-CP.
2. Annuls documents on management of medical devices.
EU Medical Device Regulatory Framework_Dec, 2022Levi Shapiro
Overview of the EU medical technology and digital health regulatory framework by Ulf Grundmann and Elisabeth Kohoutek of King & Spalding LLP. Topics include regulatory scope and definitions, classification and conformity assessment, placing a device on the EU Market, UDI and EUDAMED, Supply Chain Obligations, PMS and Vigilance. MDR covers diagnosis, prevention, monitoring, prediction, prognosis, treatment, or alleviation of a disease. ‘Medical Devices’ means any instrument, apparatus, appliance, software, implant, reagent, material or other article intended by the manufacturer to be used, alone or in combination, for human beings. The Regulation covers all devices for cleaning, sterilizing or disinfecting other medical devices, reprocessed single-use medical devices, and certain devices with no intended medical purpose.
Devices Sponsor Information Day: 3A - Medical Devices - Manufacturer's eviden...TGA Australia
Presentations by TGA and Industry (combined) to help sponsors and manufacturers better understand the regulation of medical devices and in-vitro diagnostic medical devices
Medical device and Patency
By MDD 93/42
Any devices including an instrument, apparatus, appliance, implant, material or other article, whether used alone or in combination, including a software or an accessory, intended by its manufacturer to be used specially for human beings or animals which does not achieve the primary intended action in or on human body or animals by any pharmacological or immunological or metabolic means, but which may assist in its intended function by such means for one or more of the specific purposes of ―
diagnosis, prevention, monitoring, treatment or alleviation of any disease or disorder;
diagnosis, monitoring, treatment, alleviation or assistance for, any injury or disability;
investigation, replacement or modification or support of the anatomy or of a physiological process;
supporting or sustaining life;
disinfection of medical devices; and
control of conception.
What is 510(k) ?
A 510(k) is a premarket submission made to FDA to demonstrate
that the device to be marketed is as safe and effective, that is,
substantially equivalent, to a legally marketed device
(section 513(i)(1)(a) FD&C act).
Medical Devices are notified as DRUGS under Drugs & Cosmetics Act. Section 3 (b) (iv) defines,
Medical Devices as “Devices intended for internal or external use in the diagnosis, treatment, mitigation or prevention of disease or disorder in human beings or animals”
India had no regulation for medical devices in place prior to 2005.
The import, manufacturing, distribution and Sale of medical devices in India are overseen by the Drugs and Cosmetics Act (1940) and Rules (1945)
Control and inspection are carried out by the CDSCO, state drug controllers and central/state laboratories.
Similar to Recognition of CE certificates on medical devices in Ukraine. Registration procedure during martial law: Pros and cons (20)
- підходи до проведення оцінки відповідності медичних виробів;
- як та який вид оцінки відповідності обрати;
- різниця між видами оцінки відповідності.
Документація пост-маркетингу: PMS, PMCF, PSUR, SSCP. Що з нею робити?Improve Medical LLC
ПЛАН ВЕБІНАРУ:
- З чого складається документація пост-маркетингу?
- В чому різниця між європейською та українською системою пост-маркетингу?
- Де шукати підказки по заповненню документації?
- На що звертати увагу під час підготовки?
Як та навіщо проводити клінічне оцінювання медичного виробу? Вимоги та поради...Improve Medical LLC
ПЛАН:
- коли потрібно проводити клінічне дослідження, а коли достатньо клінічного оцінювання?
- які наукометричні бази даних можна використовувати для клінічного оцінювання?
- вимоги MDR до клінічного оцінювання: що змінилося?
Управління документацією: як побудувати ефективну структуру?Improve Medical LLC
ПЛАН ВЕБІНАРУ:
- Чому Настанова якості - основний документ будь-якої СУЯ?
- Ієрархія документів на підприємстві;
- Чи потрібен електронний документообіг? Переваги та недолік.
Що таке медичний виріб? Як правильно визначити клас медичного виробу та обрат...Improve Medical LLC
ПЛАН ВЕБІНАРУ:
- Медичний виріб та його ознаки. Вироби 1-го класу та аксесуари;
- Від чого залежить процедура оцінки відповідності?
- Як підготуватися до оцінки відповідності?
- Коли потрібен лист від органу щодо належності до 1-го класу?
Чому відтерміновують регулювання MDR в ЄС? Чи вплине це на Український ринок?Improve Medical LLC
ПЛАН ВЕБІНАРУ:
- Чому відтерміновують Регулювання 2017/745 для медичних виробів? Як це вплине на ринок ЄС?
- Як національному виробнику підготуватися до сертифікації медичних виробів в ЄС під час воєнного стану?
- Чого стосуються потенційні зміни щодо MDR? Чи вплинуть вони на імпорт медичних виробів в Україну?
Історія стандартизації. Навіщо потрібна оцінка відповідності, 30.12.2022Improve Medical LLC
ПЛАН ВЕБІНАРУ:
- Коли виникла необхідність у стандартизації?
- Як люди почали розуміти свої потреби?
- Як людство прийшло до оцінки відповідності і навіщо вона нам?
Постмаркетинговий нагляд за медичними виробами в умовах воєнного стану. Плану...Improve Medical LLC
ПЛАН ВЕБІНАРУ:
- Процедура постмаркетингового нагляду за медичними виробами в умовах воєнного стану
- Система обробки скарг. Що потрібно знати про інформування виробника про скарги?
- Прийом, оформлення та зберігання інформації щодо небажаних ефектів та інциндентів.
- Як планувати систему пост-маркетингового нагляду?
Управління компетентністю персоналу. Як забезпечити ефективність процесу навч...Improve Medical LLC
ПЛАН ВЕБІНАРУ:
- огляд вимог стандартів до компетентності персоналу (ISO 13485; ISO 9001; HACCP);
- новинка – ДСТУ ISO 10015:2021 Настанови щодо управління компетентністю та щодо розвитку персоналу;
- процес забезпечення компетентності персоналу – типові етапи;
- показники результативності процесу навчання та процедури оцінювання компетентності персоналу.
Оцінка відповідності медичних виробів технічним регламентам під час воєнного...Improve Medical LLC
Владислав Касьяненко, аудитор, експерт команди IMPROVE MEDICAL у своєму виступі розповів про особливості оцінки відповідності медичних виробів вимогам технічних регламентів в умовах війни, у тому числі шляхом визнання результатів оцінки відповідності, проведеної в ЄС.
Презентація вебінару "Особливості виробництва за схемою OBL-OEM. Як забезпечи...Improve Medical LLC
ПЛАН ВЕБІНАРУ:
- яка різниця між легальним та фактичним виробником?
- як працює схема OEM-OBL?
- які документи необхідно мати легальному виробнику для реалізації медичних виробів?
Презентація вебінару "Моніторинг процесів: як встановити правильні KPI", 31.1...Improve Medical LLC
ПЛАН ВЕБІНАРУ:
- вимоги ДСТУ ISO 13485:2018 та інших стандартів до моніторингу та вимірювання процесів;
- взаємозв’язок процесів: як має працювати взаємодія?
- аналіз результативності процесів: як часто проводити?
Презентація вебінару "Визнання сертифікатів MDR: як це працює?", 28.10.2022Improve Medical LLC
ПЛАН ВЕБІНАРУ:
- нормативна база щодо визнання європейських сертифікатів;
- чи очікувати зміни у законодавстві щодо регулювання медичних виробів в Україні?
- підготовка документації по визнанню на час воєнного стану.
Презентація вебінару "Критичні аспекти СУЯ при проходженні зовнішніх аудитів"...Improve Medical LLC
ПЛАН ВЕБІНАРУ:
- Як підготувати СУЯ до проходження зовнішніх аудитів?
- Топ невідповідностей від інспекторів та органів;
- Перевіряючі - не вороги;
- Як оперативно закривати невідповідності та поліпшувати систему?
Презентація вебінару "Внутрішня кухня органу з оцінки відповідності: як відбу...Improve Medical LLC
ПЛАН ВЕБІНАРУ:
- процес оцінки відповідності з точки зору органу;
- порядок підбору аудиторів та технічних експертів;
-на що звертає увагу орган під час аналізу документації?
Презентація вебінару " “Гострі кути” при впровадженні систем управління якіст...Improve Medical LLC
ПЛАН ВЕБІНАРУ:
З чого варто починати при впровадженні СУЯ?
Немає системи – немає продажів;
На що варто звернути увагу операторам ринку, які вже впровадили СУЯ?
Flu Vaccine Alert in Bangalore Karnatakaaddon Scans
As flu season approaches, health officials in Bangalore, Karnataka, are urging residents to get their flu vaccinations. The seasonal flu, while common, can lead to severe health complications, particularly for vulnerable populations such as young children, the elderly, and those with underlying health conditions.
Dr. Vidisha Kumari, a leading epidemiologist in Bangalore, emphasizes the importance of getting vaccinated. "The flu vaccine is our best defense against the influenza virus. It not only protects individuals but also helps prevent the spread of the virus in our communities," he says.
This year, the flu season is expected to coincide with a potential increase in other respiratory illnesses. The Karnataka Health Department has launched an awareness campaign highlighting the significance of flu vaccinations. They have set up multiple vaccination centers across Bangalore, making it convenient for residents to receive their shots.
To encourage widespread vaccination, the government is also collaborating with local schools, workplaces, and community centers to facilitate vaccination drives. Special attention is being given to ensuring that the vaccine is accessible to all, including marginalized communities who may have limited access to healthcare.
Residents are reminded that the flu vaccine is safe and effective. Common side effects are mild and may include soreness at the injection site, mild fever, or muscle aches. These side effects are generally short-lived and far less severe than the flu itself.
Healthcare providers are also stressing the importance of continuing COVID-19 precautions. Wearing masks, practicing good hand hygiene, and maintaining social distancing are still crucial, especially in crowded places.
Protect yourself and your loved ones by getting vaccinated. Together, we can help keep Bangalore healthy and safe this flu season. For more information on vaccination centers and schedules, residents can visit the Karnataka Health Department’s official website or follow their social media pages.
Stay informed, stay safe, and get your flu shot today!
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...GL Anaacs
Contact us if you are interested:
Email / Skype : kefaya1771@gmail.com
Threema: PXHY5PDH
New BATCH Ku !!! MUCH IN DEMAND FAST SALE EVERY BATCH HAPPY GOOD EFFECT BIG BATCH !
Contact me on Threema or skype to start big business!!
Hot-sale products:
NEW HOT EUTYLONE WHITE CRYSTAL!!
5cl-adba precursor (semi finished )
5cl-adba raw materials
ADBB precursor (semi finished )
ADBB raw materials
APVP powder
5fadb/4f-adb
Jwh018 / Jwh210
Eutylone crystal
Protonitazene (hydrochloride) CAS: 119276-01-6
Flubrotizolam CAS: 57801-95-3
Metonitazene CAS: 14680-51-4
Payment terms: Western Union,MoneyGram,Bitcoin or USDT.
Deliver Time: Usually 7-15days
Shipping method: FedEx, TNT, DHL,UPS etc.Our deliveries are 100% safe, fast, reliable and discreet.
Samples will be sent for your evaluation!If you are interested in, please contact me, let's talk details.
We specializes in exporting high quality Research chemical, medical intermediate, Pharmaceutical chemicals and so on. Products are exported to USA, Canada, France, Korea, Japan,Russia, Southeast Asia and other countries.
NVBDCP.pptx Nation vector borne disease control programSapna Thakur
NVBDCP was launched in 2003-2004 . Vector-Borne Disease: Disease that results from an infection transmitted to humans and other animals by blood-feeding arthropods, such as mosquitoes, ticks, and fleas. Examples of vector-borne diseases include Dengue fever, West Nile Virus, Lyme disease, and malaria.
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdfAnujkumaranit
Artificial intelligence (AI) refers to the simulation of human intelligence processes by machines, especially computer systems. It encompasses tasks such as learning, reasoning, problem-solving, perception, and language understanding. AI technologies are revolutionizing various fields, from healthcare to finance, by enabling machines to perform tasks that typically require human intelligence.
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...Oleg Kshivets
RESULTS: Overall life span (LS) was 2252.1±1742.5 days and cumulative 5-year survival (5YS) reached 73.2%, 10 years – 64.8%, 20 years – 42.5%. 513 LCP lived more than 5 years (LS=3124.6±1525.6 days), 148 LCP – more than 10 years (LS=5054.4±1504.1 days).199 LCP died because of LC (LS=562.7±374.5 days). 5YS of LCP after bi/lobectomies was significantly superior in comparison with LCP after pneumonectomies (78.1% vs.63.7%, P=0.00001 by log-rank test). AT significantly improved 5YS (66.3% vs. 34.8%) (P=0.00000 by log-rank test) only for LCP with N1-2. Cox modeling displayed that 5YS of LCP significantly depended on: phase transition (PT) early-invasive LC in terms of synergetics, PT N0—N12, cell ratio factors (ratio between cancer cells- CC and blood cells subpopulations), G1-3, histology, glucose, AT, blood cell circuit, prothrombin index, heparin tolerance, recalcification time (P=0.000-0.038). Neural networks, genetic algorithm selection and bootstrap simulation revealed relationships between 5YS and PT early-invasive LC (rank=1), PT N0—N12 (rank=2), thrombocytes/CC (3), erythrocytes/CC (4), eosinophils/CC (5), healthy cells/CC (6), lymphocytes/CC (7), segmented neutrophils/CC (8), stick neutrophils/CC (9), monocytes/CC (10); leucocytes/CC (11). Correct prediction of 5YS was 100% by neural networks computing (area under ROC curve=1.0; error=0.0).
CONCLUSIONS: 5YS of LCP after radical procedures significantly depended on: 1) PT early-invasive cancer; 2) PT N0--N12; 3) cell ratio factors; 4) blood cell circuit; 5) biochemical factors; 6) hemostasis system; 7) AT; 8) LC characteristics; 9) LC cell dynamics; 10) surgery type: lobectomy/pneumonectomy; 11) anthropometric data. Optimal diagnosis and treatment strategies for LC are: 1) screening and early detection of LC; 2) availability of experienced thoracic surgeons because of complexity of radical procedures; 3) aggressive en block surgery and adequate lymph node dissection for completeness; 4) precise prediction; 5) adjuvant chemoimmunoradiotherapy for LCP with unfavorable prognosis.
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...i3 Health
i3 Health is pleased to make the speaker slides from this activity available for use as a non-accredited self-study or teaching resource.
This slide deck presented by Dr. Kami Maddocks, Professor-Clinical in the Division of Hematology and
Associate Division Director for Ambulatory Operations
The Ohio State University Comprehensive Cancer Center, will provide insight into new directions in targeted therapeutic approaches for older adults with mantle cell lymphoma.
STATEMENT OF NEED
Mantle cell lymphoma (MCL) is a rare, aggressive B-cell non-Hodgkin lymphoma (NHL) accounting for 5% to 7% of all lymphomas. Its prognosis ranges from indolent disease that does not require treatment for years to very aggressive disease, which is associated with poor survival (Silkenstedt et al, 2021). Typically, MCL is diagnosed at advanced stage and in older patients who cannot tolerate intensive therapy (NCCN, 2022). Although recent advances have slightly increased remission rates, recurrence and relapse remain very common, leading to a median overall survival between 3 and 6 years (LLS, 2021). Though there are several effective options, progress is still needed towards establishing an accepted frontline approach for MCL (Castellino et al, 2022). Treatment selection and management of MCL are complicated by the heterogeneity of prognosis, advanced age and comorbidities of patients, and lack of an established standard approach for treatment, making it vital that clinicians be familiar with the latest research and advances in this area. In this activity chaired by Michael Wang, MD, Professor in the Department of Lymphoma & Myeloma at MD Anderson Cancer Center, expert faculty will discuss prognostic factors informing treatment, the promising results of recent trials in new therapeutic approaches, and the implications of treatment resistance in therapeutic selection for MCL.
Target Audience
Hematology/oncology fellows, attending faculty, and other health care professionals involved in the treatment of patients with mantle cell lymphoma (MCL).
Learning Objectives
1.) Identify clinical and biological prognostic factors that can guide treatment decision making for older adults with MCL
2.) Evaluate emerging data on targeted therapeutic approaches for treatment-naive and relapsed/refractory MCL and their applicability to older adults
3.) Assess mechanisms of resistance to targeted therapies for MCL and their implications for treatment selection
Title: Sense of Taste
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the structure and function of taste buds.
Describe the relationship between the taste threshold and taste index of common substances.
Explain the chemical basis and signal transduction of taste perception for each type of primary taste sensation.
Recognize different abnormalities of taste perception and their causes.
Key Topics:
Significance of Taste Sensation:
Differentiation between pleasant and harmful food
Influence on behavior
Selection of food based on metabolic needs
Receptors of Taste:
Taste buds on the tongue
Influence of sense of smell, texture of food, and pain stimulation (e.g., by pepper)
Primary and Secondary Taste Sensations:
Primary taste sensations: Sweet, Sour, Salty, Bitter, Umami
Chemical basis and signal transduction mechanisms for each taste
Taste Threshold and Index:
Taste threshold values for Sweet (sucrose), Salty (NaCl), Sour (HCl), and Bitter (Quinine)
Taste index relationship: Inversely proportional to taste threshold
Taste Blindness:
Inability to taste certain substances, particularly thiourea compounds
Example: Phenylthiocarbamide
Structure and Function of Taste Buds:
Composition: Epithelial cells, Sustentacular/Supporting cells, Taste cells, Basal cells
Features: Taste pores, Taste hairs/microvilli, and Taste nerve fibers
Location of Taste Buds:
Found in papillae of the tongue (Fungiform, Circumvallate, Foliate)
Also present on the palate, tonsillar pillars, epiglottis, and proximal esophagus
Mechanism of Taste Stimulation:
Interaction of taste substances with receptors on microvilli
Signal transduction pathways for Umami, Sweet, Bitter, Sour, and Salty tastes
Taste Sensitivity and Adaptation:
Decrease in sensitivity with age
Rapid adaptation of taste sensation
Role of Saliva in Taste:
Dissolution of tastants to reach receptors
Washing away the stimulus
Taste Preferences and Aversions:
Mechanisms behind taste preference and aversion
Influence of receptors and neural pathways
Impact of Sensory Nerve Damage:
Degeneration of taste buds if the sensory nerve fiber is cut
Abnormalities of Taste Detection:
Conditions: Ageusia, Hypogeusia, Dysgeusia (parageusia)
Causes: Nerve damage, neurological disorders, infections, poor oral hygiene, adverse drug effects, deficiencies, aging, tobacco use, altered neurotransmitter levels
Neurotransmitters and Taste Threshold:
Effects of serotonin (5-HT) and norepinephrine (NE) on taste sensitivity
Supertasters:
25% of the population with heightened sensitivity to taste, especially bitterness
Increased number of fungiform papillae
263778731218 Abortion Clinic /Pills In Harare ,sisternakatoto
263778731218 Abortion Clinic /Pills In Harare ,ABORTION WOMEN’S CLINIC +27730423979 IN women clinic we believe that every woman should be able to make choices in her pregnancy. Our job is to provide compassionate care, safety,affordable and confidential services. That’s why we have won the trust from all generations of women all over the world. we use non surgical method(Abortion pills) to terminate…Dr.LISA +27730423979women Clinic is committed to providing the highest quality of obstetrical and gynecological care to women of all ages. Our dedicated staff aim to treat each patient and her health concerns with compassion and respect.Our dedicated group ABORTION WOMEN’S CLINIC +27730423979 IN women clinic we believe that every woman should be able to make choices in her pregnancy. Our job is to provide compassionate care, safety,affordable and confidential services. That’s why we have won the trust from all generations of women all over the world. we use non surgical method(Abortion pills) to terminate…Dr.LISA +27730423979women Clinic is committed to providing the highest quality of obstetrical and gynecological care to women of all ages. Our dedicated staff aim to treat each patient and her health concerns with compassion and respect.Our dedicated group of receptionists, nurses, and physicians have worked together as a teamof receptionists, nurses, and physicians have worked together as a team wwww.lisywomensclinic.co.za/
Recognition of CE certificates on medical devices in Ukraine. Registration procedure during martial law: Pros and cons
1. RECOGNITION OF CE CERTIFICATES ON MD IN UKRAINE.
REGISTRATION PROCEDURE DURING MARTIAL LAW
Vladyslav Kasianenko
Audotor at Improve Medical CAB
2.
3. The market of medical devices in Ukraine
Before russian ivasion (24 of February, 2022) After russian ivasion (24 of February, 2022)
Stable growing market of medical devices expands
the opportunities for manufacturers, distributors,
customers and for state in general.
Still stable, still growing, but with changing diversity
(more MD for military and emergency treatment),
increasing cost of final product etc
Project for adaptation of requirements of MDR to
Ukrainian Regulation (now we have Technical
Regulation Equivalent to MDD)
The project is delayed on uncertain period
Ukrainian manufacturers and other economic
operators started to integrate the requirements of
MDR into their QMS and applied to EU NB.
All applications are paused until the end of martial
law.
Part of medical devices in Medicinal/Pharmaceutical
basket reached 8,5%
Full uncertainty
4. Legislation of Ukraine that
applied to medical devices
ISO/IEC 17021
ISO/IEC 17065
Technical Regulation
on Medical Devices
for IVD (Regulation
754)
Law of Ukraine "On
Standardization"
Technical regulations
for active implantable
medical devices
(Decree 755)
Technical regulations
for medical devices
(Decree 753)
Law of Ukraine "On
General Safety of
Non-Food Products"
Law of Ukraine "On
State Market
Supervision and Control
of Non-Food Products"
Law of Ukraine "On
Accreditation of
Conformity
Assessment Bodies"
Law of Ukraine "On
Technical Regulations
and Conformity
Assessment"
6. Decree № 389 dated 29.03.2022
To establish that for the period of martial law the introduction to the market of all medical devices, for which
the requirements of the Technical Regulation approved by this resolution are not met, is allowed if Ukrainian
conformity assessment body recognizes the results of conformity assessment performed by foreign
conformity assessment body in accordance with the requirements of parts one and three of Article 45 of the
Law of Ukraine “On Technical Regulations and Conformity Assessment”.
7. Law of Ukraine "On Technical Regulations and ConformityAssessment"
Section VIII RECOGNITION OF CONFORMITY ASSESSMENT RESULTS
Article 45. Recognition of the results of conformity assessment conducted outside Ukraine
1. The results of conformity assessment of technical regulations conducted in another country shall be accepted and
recognized in Ukraine if the conformity assessment procedures applied in that country (even if they differ from Ukrainian
procedures) provide the same level of conformity to the relevant technical regulations as Ukrainian conformity assessment
procedures.
2. Documents on compliance with the requirements of technical regulations issued as a result of conformity assessment
conducted in another state are accepted if Ukraine and another state have concluded an international agreement of Ukraine on
mutual recognition of the results of conformity assessment
3. Designated bodies have the right to recognize the results of conformity assessment of technical regulations
conducted by foreign accredited conformity assessment bodies on the basis of agreements with such conformity
assessment bodies, if:
• national accreditation bodies that accredit conformity assessment bodies both in Ukraine and in another country are
members of an international or regional accreditation organization and / or have concluded a mutual recognition
agreement with such organization regarding the relevant conformity assessment activities;
• the designated body, on the basis of a conformity assessment document issued by a foreign conformity assessment
body, applies the conformity assessment procedure or part thereof and issues the conformity assessment
document provided for in this procedure under its responsibility.
8. Law of Ukraine "On Technical Regulations and ConformityAssessment"
The results of conformity assessment of technical regulations conducted in another state shall be accepted
and recognized in Ukraine if the conformity assessment procedures applied in that state (even if they differ
from Ukrainian procedures) provide the same level of conformity to the relevant technical regulations as
Ukrainian conformity assessment procedures.
Technical regulations for medical
devices (CMU Resolution 753)
Technical regulations for medical
devices for in-vitro diagnostics (CMU
Resolution 754)
Technical regulations for active
implantable medical devices (CMU
Resolution 755)
Drafted on the basis of the EU Council Directive of 14 June 1993 №
93/42 / EEC on medical devices
Drafted on the basis of Directive 98/79 / EEC of the European
Parliament and of the Council of 27 October 1998 on in vitro
diagnostic medical devices.
Developed on the basis of the EU Council Directive of 20 June 1990
№ 90/385 / EEC on the approximation of the laws of the Member
States relating to active implantable medical devices.
9. Usual ways of conformity
assessment of Ukraine for
medical devices
Onsite
regular audit
Recognition of NB
conformity
assessment
results
Remote audits
(implemented
once the COVID
began)
10. Onsite regular audit
Standard way of conformity assessment:
• Requires the onsite presence of auditors
• Involves more documentation from both sites
• Equivalent to MDD
The manufacturers of medical devices passed
the conformity assessment onsite and placed on
the market /put into service in Ukraine receive
the certificate for their MD for 5 years with further
yearly surveillance.
1
11. List of documents attached to the application for conducting
conformity assessment procedure (on-site audit)
12. List of documents attached to the application for conducting
conformity assessment procedure (on-site audit)
13. Recognition Procedure
Faster way of conformity assessment:
• Do not require the onsite presence of auditors
• Less documentation and lower cost
• Performed on a basis of an Agreement with
European Notified Body
The manufacturers of medical devices passed
the conformity assessment by recognition
procedure and placed on the market /put into
service in Ukraine receive the certificate for their
MD on the basis of CE certificate issued by NB
with further yearly surveillance.
2
14. Agreement on recognition of conformity
assessment results
The process of signing the Agreement
with a EU notified body is a very
significant process that requires lengthy
negotiations, confirmation of the
competence of the Ukrainian side and
accreditation certificate.
2
Developed taking into account the comments of European notified bodies, and in
accordance with ISO / IEC Guide 68 "Agreements on the recognition and
acceptance of conformity assessment results".
15. List of documents attached to the application for conducting
conformity assessment procedure (recognition procedure)
16. The conformity assessment body Improve Medical has simplified
the list of necessary documentation for the recognition of CE
certificates during martial law.
This decision was made in order to let the high quality medical
devices enter the marker more fast.
17. List of documents attached to the application for conducting
conformity assessment procedure (recognition during martial law)
18. List of documents attached to the application for conducting
conformity assessment procedure (recognition during martial law)
19. Remote audits
• Both operator and auditors are present online
• Involves a lot of additional documentation from both sites: Checklists, risk
analysis and approval from both sites
3
During remote audits it is necessary
to provide the stable Internet
connection from both sides, more
time for analyzation before the audit
and an opportunity for auditors to
verity all manufacturing processes
(streaming and guiding of person
who holds the camera)
20. As part of the conformity assessment procedure, the manufacturer should confirm the
compliance of medical devices with the requirements of Annex 1 of the Technical
Regulations. This requirement is duplicated with a similar annex set out in the relevant EU
Directives and is called the Essential Requirements (Checklist).
Such requirements are made out in the table which is well known to the manufacturer.
Although the Technical Regulations are based on the EU Directives, the structure of the
Essential Requirements is somewhat different from the structure of the Essential
Requirements of the EU Directives.
Check-list (Essential requirement according to Annex 1 of
Ukrainian Technical / (Essential Requirements) / General
Safety and Performance Requirements
22. .
Language of instruction and labeling
Labeling of goods, instructions for their use, etc. are performed in the state
language and in the regional or minority language. According to the decision of
the producers of goods, its translation into other languages may be placed next to
the text presented in the state language. Labeling of goods for export is
performed in any language.
The information on the packaging of the medical device will be studied by the consumer, who in accordance with the
Law "On Consumer Protection" has the right to receive the necessary, reliable and timely information.
LAW OF UKRAINE
On ensuring the functioning of the Ukrainian language as the state language
(Information of the Verkhovna Rada (VRU), 2019, № 21, p.81)
23. UA.TR.000
The identification number of the conformity assessment body shall be
indicated next to the conformity mark, if the involvement of the body
is provided by the relevant procedure.
Medical devices:
The mark of conformity shall be applied at the decision of the manufacturer on medical devices or on
its packaging, as well as to the instructions for use, if such a document is used.
Medical devices for in-vitro diagnostics: The mark of conformity shall apply to the
instructions for use, if such instructions are required, and to the outer packaging, and if
possible to the medical device itself.
24. Declaration of conformity
The Technical Regulation for medical devices of Ukraine do not specify the requirements for the
content, approximate structure or form of the declaration of conformity. Thus, the form of the
Declaration is free.
Basic information to be provided in the Declaration:
Name of medical device (s);
Manufacturer's name;
Name of production sites;
Name of authorized representative;
Product classification (all possible modifications);
Conformity assessment procedure, number of the
Technical Regulation;
Information that the medical device meets the basic
requirements of the relevant TR;
Date and information about the person signing the
declaration;
Validity of the declaration of conformity;
Link to version and technical file number (if applicable)